Cargando…
Bronchodilator Delivery via High-Flow Nasal Cannula: A Randomized Controlled Trial to Compare the Effects of Gas Flows
(1) Background: Aerosol delivery via high-flow nasal cannula (HFNC) has attracted increasing clinical interest. In vitro studies report that the ratio of HFNC gas flow to patient inspiratory flow (GF:IF) is a key factor in the efficiency of trans-nasal aerosol delivery. (2) Methods: In a randomized...
Autores principales: | Li, Jie, Chen, Yibing, Ehrmann, Stephan, Wu, Jie, Xie, Lixin, Fink, James B |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8539308/ https://www.ncbi.nlm.nih.gov/pubmed/34683948 http://dx.doi.org/10.3390/pharmaceutics13101655 |
Ejemplares similares
-
Effects of flow rate on transnasal pulmonary aerosol delivery of bronchodilators via high-flow nasal cannula for patients with COPD and asthma: protocol for a randomised controlled trial
por: Li, Jie, et al.
Publicado: (2019) -
High-flow nasal cannula for COVID-19 patients: risk of bio-aerosol dispersion
por: Li, Jie, et al.
Publicado: (2020) -
The Ratio of Nasal Cannula Gas Flow to Patient Inspiratory Flow on Trans-nasal Pulmonary Aerosol Delivery for Adults: An in Vitro Study
por: Li, Jie, et al.
Publicado: (2019) -
High-flow nasal cannula for COVID-19 patients: low risk of bio-aerosol dispersion
por: Li, Jie, et al.
Publicado: (2020) -
Nasal high-flow bronchodilator nebulization: a randomized cross-over study
por: Reminiac, François, et al.
Publicado: (2018)